Takeda Pharmaceutical
TAK
#479
Rank
S$62.22 B
Marketcap
S$18.70
Share price
0.73%
Change (1 day)
5.94%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): S$2.58 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are S$29.52 Billion. In 2024 the company made an earning of S$2.88 Billion a decrease over its 2023 earnings that were of S$2.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$2.58 B-10.22%
2024 S$2.88 B-2.41%
2023 S$2.95 B-28.14%
2022 S$4.11 B-40.9%
2021 S$6.95 B78.24%
2020 S$3.90 B246.1%
2019 S$1.12 B-48.79%
2018 S$2.20 B-23.64%
2017 S$2.88 B21.7%
2016 S$2.36 B-253.01%
2015 -S$1.55 Billion-159.65%
2014 S$2.59 B13%
2013 S$2.29 B2.46%
2012 S$2.24 B-57.05%
2011 S$5.21 B-10.49%
2010 S$5.83 B-3.99%
2009 S$6.07 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.85 B 1,481.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.75 B 344.15%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
S$15.31 B 478.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.21 B 701.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-S$1.03 Billion-138.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$1.18 B-55.15%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
S$10.64 B 302.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$12.04 B 355.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$29.82 B 1,026.95%๐Ÿ‡บ๐Ÿ‡ธ USA